RE: Monthly Cash Generation14 Jun 2020 14:35
"
Also a company isn’t valued at exactly the profit they earn a year, pharmas are usually valued at a 10-15 PE ratio. Obviously I doubt we’d receive the 10-15 ratio, so let’s use a conservative PE of 5, at £20mil per month profit (very low estimate), that’s £240mil in the year, £1.2billion valuation."
But how do you factor in the finite nature (in scale at least) of the covid sales?